Global Genome Editing Market Report 2022: Developing Biotechnology Industry in Emerging Regions Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Genome Editing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Technology, Application, and End User” report has been added to ResearchAndMarkets.com’s offering. The genome editing market is projected to reach US$ 16,986.69 million by 2028 from US$ 5,199.40 million in 2021; it is expected to grow at a CAGR of … [Read more…]

Blood Collection Tubes for Liquid Biopsy Market Report 2022: Rise in Demand for Minimally Invasive Diagnostic Tests & Increase in Prevalence of Cancer Worldwide Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Blood Collection Tubes for Liquid Biopsy Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product, Material, Application, End User” report has been added to ResearchAndMarkets.com’s offering. The blood collection tubes for liquid biopsy market is projected to reach US$ 256.26 million by 2028 from US$ 79.03 million in 2021. It … [Read more…]

microRNA (miRNA) Global Market Report 2022: Increasing Incidence of Infectious Diseases and Chronic Conditions to Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “microRNA (miRNA) – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global microRNA (miRNA) Market to Reach $485.3 Million by 2026 Key drivers propelling growth in the global microRNA market include greater awareness, increasing emphasis on R&D activities, growth of advanced and well-organized technology, rising government initiatives globally, escalating … [Read more…]

Respiratory Inhalers Global Market Report 2022: Growing Homecare Market Drives Demand for Respiratory Diagnostic and Therapy Devices – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Respiratory Inhalers – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Respiratory Inhalers Market to Reach $48.7 Billion by 2026 Respiratory care market occupies a significant presence in the medical field, as respiratory dysfunction is among the most widespread healthcare problem globally. Growth drivers include increasing incidence of … [Read more…]

Global In Silico Clinical Trials Market Report 2022: Growing Demand for Clinical Trials That Are Cost-Effective, Time-Efficient, & Avoid Animal Cruelty Fueling Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global In Silico Clinical Trials Market, By Industry (Medical Devices v/s Pharmaceuticals), By Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases, Orthopedic, Dermatology, Others), By Region, Competition Forecast and Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. The Global in Silico Clinical Trials Market was valued to be USD2743.64 million in the year … [Read more…]

Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022

NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced that Mr. Darren Lui, CEO and Executive Director of Aptorum Group will present both in-person and virtually at the H.C. Wainwright … [Read more…]

Henry Schein to Present at Two Investor Conferences in September

MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Morgan Stanley 20th Annual Global Healthcare Conference at the Grand Hyatt in New York on September 12, 2022, at 9:20 … [Read more…]

Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update

VANCOUVER, B.C.–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today reported financial results and provided a corporate update for the second quarter ended June 30, 2022. “The Company released … [Read more…]

Athersys Announces 1-for-25 Reverse Stock Split

CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-25 after the close of trading on the Nasdaq Stock Market on Friday, August 26, 2022. Athersys … [Read more…]

Baxter to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:35 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be … [Read more…]